| Literature DB >> 24175992 |
Tao Xu, Lulong Bo, Jiafeng Wang, Zhenzhen Zhao, Zhiyun Xu, Xiaoming Deng, Wenzhong Zhu1.
Abstract
BACKGROUND: The present study was performed to investigate the incidence of early postoperative cognitive dysfunction (POCD) after non-coronary bypass surgery and the potential risk factors in Chinese population.Entities:
Mesh:
Year: 2013 PMID: 24175992 PMCID: PMC3818927 DOI: 10.1186/1749-8090-8-204
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Demographics of patients
| Age (years) | 41.7 ± 18.7 |
| Gender (M/F) | 94/82 |
| BMI | 21.0 ± 3.9 |
| Education background | |
| <3 years (%) | 14 (8.0) |
| 3-6 years (%) | 50 (28.4) |
| 7-9 years (%) | 64 (36.4) |
| 9-12 years (%) | 32 (18.2) |
| >12 years (%) | 16 (9.1) |
| Surgical type | |
| Congenital disease(%) | 52 (29.5) |
| Valvular disease (%) | 86 (48.9) |
| Aorta disease (%) | 34 (19.3) |
| Tumor (%) | 4 (2.3) |
| Hypertension (%) | 26 (14.8) |
| ASA (II/III/IV) | 102/56/18 |
| NYHA (I/II/III/IV) | 21/97/50/8 |
| EF (%) | 61.4 ± 8.3 |
NOTE. Data were expressed as number (%) or mean ± standard deviation. M, male; F, female; BMI, body mass index; ASA, American Society of Anesthesiologists score; NYHA, New York Heart Association cardiac functional classification; EF, ejection fraction.
Surgical and anesthetic data
| Head-down position (%) | 142 (80.7) |
| Surgical duration (h) | 3.3 ± 1.0 |
| Anesthesia duration (h) | 4.1 ± 1.2 |
| CPB duration (min) | 89.3 ± 33.1 |
| CC duration (min) | 50.6 ± 23.1 |
| Rewarming duration (min) | 33.6 ± 1.6 |
| Midazolam dose (mg) | 10.6 ± 2.9 |
| Etomidate dose (mg) | 25.4 ± 9.9 |
| Sufentanil dose (μg) | 262.8 ± 107.1 |
| Sevoflurane concentration (%) | 2.0 ± 1.1 |
NOTE. CPB, cardiopulmonary bypss; CC, cross-clamp.
Univariate analysis of early POCD after non-CABG cardiac surgery
| Age | 45.9 ± 17.9 | 39.6 ± 19.8 | 0.040 |
| Gender (M/F) | 32/26 | 62/56 | 0.742 |
| BMI | 20.5 ± 3.6 | 21.2 ± 3.9 | 0.239 |
| Education background | | | 0.122 |
| <3 years (%) | 3 | 11 | |
| 3-6 years (%) | 22 | 28 | |
| 7-9 years (%) | 22 | 42 | |
| 9-12 years (%) | 10 | 22 | |
| >12 years (%) | 2 | 14 | |
| Surgical type | | | 0.051 |
| Congenital disease | 10 | 42 | |
| Valvular disease (%) | 32 | 54 | |
| Aorta disease (%) | 14 | 20 | |
| Tumor (%) | 2 | 2 | |
| Hypertension (%) | 10 | 16 | 0.518 |
| ASA (II/III/IV) | 24/24/10 | 78/32/8 | 0.005 |
| NYHA (I/II/III/IV) | 10/33/18/2 | 11/66/32/6 | 0.309 |
| EF (%) | 61 | 63 | 0.688 |
| Hypertension (%) | 62.8 ± 8.5 | 60.8 ± 8.1 | 0.173 |
| Head-down position (%) | 15.4 | 10.9 | 0.419 |
| Surgical duration (h) | 3.7 ± 1.4 | 3.1 ± 0.8 | 0.003 |
| Anesthesia duration (h) | 4.6 ± 1.5 | 3.8 ± 0.8 | 0.001 |
| CPB duration (min) | 105.2 ± 37.8 | 82.1 ± 28.0 | <0.001 |
| CC duration (min) | 61.3 ± 26.0 | 45.8 ± 19.9 | <0.001 |
| Rewarming duration (min) | 32.8 ± 2.2 | 34.0 ± 1.1 | <0.001 |
| Midazolam dose(mg) | 10.3 ± 3.5 | 10.7 ± 2.6 | 0.502 |
| Etomidate dose (mg) | 27.2 ± 11.1 | 24.4 ± 9.1 | 0.108 |
| Sufentanil dose (μg) | 282.2 ± 118.8 | 252.8 ± 99.8 | 0.122 |
NOTE. Date are expressed as number (%) or mean ± standard deviation. M, male; F, female; BMI, body mass index; ASA, American Society of Anesthesiologists score; NYHA, New York Heart Association cardiac functional classification; EF, ejection fraction. CPB, cardiopulmonary bypass; CC, cross-clamp. Variables with a p < 0.01 was included in the multivariate analysis.
Multivariate analysis of early POCD after non-CABG cardiac surgery
| Age | 0.29 | 0.043 | 1.34 (1.01-1.78) |
| Anesthesia duration | 0.44 | 0.053 | 1.55 (1.00-2.41) |
| CC duration | 0.77 | 0.028 | 2.167 (1.09-4.32) |
| Sevoflurane concentration | -0.68 | 0.000 | 0.505 (0.34-0.74) |
NOTE. CC, cross-clamp.